Recipharm completes Blow-fill-seal expansion at Kaysersberg facility

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at its facility in Kaysersberg, France. .

Novartis changes its executive committees to align with its strategic goals

Novartis announced changes to its senior leadership team to support the implementation of its strategic priorities. Bertrand Bodson, Chief Digital Officer, Steffen Lang, Global Head Novartis Technical Operations...

Thermo Fisher Scientific Named Industry Week Best Plants Award Winner 2017

An expert judging panel of Industry Week editors and advisors has selected the Thermo Fisher Scientific Auburn manufacturing site in Alabama as one of seven 2017 Best Plant winners.

Sarepta Therapeutics gazes FDA approval of Golodirsen in Patients with DMD Amenable to Skipping Exon 53

Sarepta Therapeutics Inc , a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases.

Largest Real-World Data Analysis Reveals Findings of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants

BMS and Pfizer Inc. will present findings from a RWD analysis titled, Comparison of Effectiveness, Safety, and the Net Clinical Outcome between Different Direct Oral..

Ian Rentsch is Clinerion's new CEO

Clinerion's Board of Directors announces the appointment of Ian Rentsch as new CEO of the company, effective April 1, 2018.Clinerion, the leading supplier of patient data analytics services for clinical trial patient search and identification, and data generation for real-world evidence and market access..

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2018 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com